Summary: | 碩士 === 國立臺灣科技大學 === 電機工程系 === 105 === Abstract
Alginate is a non-toxic, biodegradable, and naturally occurring polysaccharide found in marine brown algae. It has been used in many drug delivery systems for a long history due to its biodegradability and biocompatibility. This study aimed to encapsulate doxorubicin using alginate via electrospray method and assessed the capacity of the encapsulating drug carriers to kill liver cancer cells through cell viability assay. And this particle can also cause embolization in brood vessel at liver cancer site. It will lead the apoptosis of the liver cancer.
Formulation of alginate-based particles was firstly done using the electrospray method. Preliminary results include encapsulation of stock solution with various pH value, and different applied voltage during electrospray process and addition of CTAB as surfactant to harvest the smaller size and shape of particle.
Our results showed that the MPs produced from the following condition (flow rate: 4.0 µl/min, WD: 13.0 cm, voltage: 8.0 kV, pH: 7.13, Needle length: 0.6 cm) exhibited smallest size, and was confirmed that DOX is encapsulated in particle. The size is suitable for causing embolization of liver cancer site. MRI test was conducted to confirm whether the contrast agent USPIO is encapsulated in MPs or not and whether the particles can show MRI T2 effect when using as contrast agent. Ethylene glycol was used to disperse the MPs to prevent precipitation during acquisition procedure of MRI imaging. As a result, the USPIO in the MPs was confirmed through this test and indeed showed T2 effect in MRI imaging. By using SEM, the precise morphology of surface of the MPs was observed. The cytotoxicity of the doxorubicin encapsulating MPs to liver cancer cell HepG2 was via MTT assay. During this assay, the cells were incubated at 37℃, 5% CO2 condition. At point of 1 mM doxorubicin concentration, MPs suspended with DI water/ethylene glycol cosolvent showed inhibition rate of approximately 65% and 89% to hepatic cancer cell line HepG2, respectively.
|